Prime Capital Investment Advisors LLC grew its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 151,203 shares of the company’s stock after buying an additional 2,750 shares during the period. Prime Capital Investment Advisors LLC’s holdings in Procter & Gamble were worth $26,188,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of PG. Concurrent Investment Advisors LLC raised its position in shares of Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after purchasing an additional 4,035 shares during the period. Radnor Capital Management LLC bought a new stake in shares of Procter & Gamble during the 3rd quarter worth $5,705,000. Welch Group LLC boosted its stake in shares of Procter & Gamble by 0.9% during the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock worth $56,094,000 after acquiring an additional 2,990 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Procter & Gamble by 67.2% during the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after acquiring an additional 10,777 shares in the last quarter. Finally, Quintet Private Bank Europe S.A. boosted its stake in shares of Procter & Gamble by 15.0% during the 3rd quarter. Quintet Private Bank Europe S.A. now owns 426,820 shares of the company’s stock worth $73,925,000 after acquiring an additional 55,620 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.
Insider Buying and Selling at Procter & Gamble
In related news, CEO Jon R. Moeller sold 31,797 shares of the company’s stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $5,380,688.34. Following the completion of the transaction, the chief executive officer now owns 300,777 shares in the company, valued at approximately $50,897,483.94. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 96,000 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the transaction, the chief executive officer now owns 13,721 shares of the company’s stock, valued at approximately $2,332,570. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jon R. Moeller sold 31,797 shares of the firm’s stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $5,380,688.34. Following the transaction, the chief executive officer now directly owns 300,777 shares in the company, valued at $50,897,483.94. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 313,597 shares of company stock valued at $53,268,499 over the last 90 days. 0.18% of the stock is currently owned by corporate insiders.
Procter & Gamble Trading Down 0.0 %
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same period last year, the company posted $1.83 EPS. Procter & Gamble’s revenue was down .6% on a year-over-year basis. Equities analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.43%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio is currently 69.31%.
Analysts Set New Price Targets
Several analysts recently issued reports on PG shares. Morgan Stanley increased their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. JPMorgan Chase & Co. increased their price objective on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. TD Cowen started coverage on Procter & Gamble in a report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price objective for the company. Evercore ISI increased their price objective on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Finally, Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Nine equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus target price of $177.00.
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Where to Find Earnings Call Transcripts
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.